Add BrightSurf on Google Email

The ASTRID study

The ASTRID study found that patients with high and very high risk benefited from transfemoral TAVI, with mortality rates of 4.7% and 7.7%, respectively. The registry also showed differences in vascular complications and residual aortic regurgitation between valve types.

The PROTECT study

The PROTECT study found that zotarolimus-eluting and sirolimus-eluting stents have comparable rates of stent thrombosis at three years. The study also showed that dual antiplatelet therapy use can affect the long-term clinical relevance of stent type.

The IABP-SHOCK II study

The IABP-SHOCK II trial randomized 600 patients to receive either an intraaortic balloon pump or conventional optimal medical treatment, but found no reduction in 30-day mortality rates. The study also showed that the IABP did not improve blood pressure, organ perfusion, or reduce treatment time in the intensive care unit.

Prevention is better than cure for killer cardiovascular disease

The new 2012 Joint European Societies' Guidelines on cardiovascular disease prevention in clinical practice focus on lifestyle changes, public health initiatives, and individual preventive measures to address the growing burden of CVD. Experts stress the need for a co-ordinated society-wide effort to reduce mortality.

SourceSAGE·JournalEuropean Journal of Preventive Cardiology·DateJul 6, 2012

Advanced visualization techniques could change the paradigm for diagnosis and treating heart disease

Researchers at Mount Sinai School of Medicine are pioneering a new way to diagnose heart disease by focusing on fluid dynamics, not muscle mechanics. This approach uses advanced ultrasound techniques to visualize blood flow in the heart, providing clues for early detection and effective therapeutic interventions.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of the American College of Cardiology·DateMay 31, 2012

Are people with HIV/AIDS more prone to sudden cardiac death?

Researchers conducted a 10-year retrospective study on HIV patients in San Francisco, finding that they suffered sudden cardiac death at a rate four times higher than the general population. The study suggests that HIV changes the electrophysiology of the heart, increasing the risk of conduction abnormalities and sudden death.

SourceUniversity of California - San Francisco·JournalJournal of the American College of Cardiology·DateMay 14, 2012

New criteria provide guidance about when to use cardiac catheterization to look for heart problems

A new report provides detailed criteria for clinicians to determine when cardiac catheterization is a reasonable option for evaluating patients with heart disease. The guidelines identify 166 possible clinical scenarios and assess the appropriateness of each indication, concluding that cardiac catheterization is appropriate in about ha...

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateMay 9, 2012

ACCF, SCAI publish new standards defining best practices for modern cardiac cath labs

The updated consensus statement provides guidance on setting up, operating, and maintaining high-quality cardiac catheterization laboratories. Modern cath labs now incorporate minimally invasive techniques for congenital heart defects and valvular heart disease, as well as developing hybrid labs with surgical features.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateMay 8, 2012

Novel drug in pill form safer than standard approach to treat blocked lung blood vessels

A new study found that the novel oral anti-coagulant rivaroxaban is as effective as traditional treatment for blocked lung blood vessels, with lower rates of major bleeding. The EINSTEIN-PE trial compared rivaroxaban to standard therapy and demonstrated its non-inferiority in treating pulmonary embolism.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateMar 26, 2012

Pregnancy increases risk of heart attack

A new study found that pregnancy increases the risk of heart attack, with more severe attacks and different causes than in non-pregnant women. The standard approach to managing heart attacks during pregnancy may not always be best, and alternative treatments may be needed to prevent complications.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateMar 25, 2012